Exploring Biomarkers for Early Prognosis of COVID-19-Induced Acute Kidney Injury: A Comprehensive Systematic Review

Venine Prado Saêta; Bruna Morais de Souza Neves; Thaís Reis Oliveira; Lilian Carla Carneiro; Nadya da Silva Castro Ragagnin

doi:10.34257/GJMRFVOL24IS1PG49

Authors

Venine Prado Saêta
Bruna Morais de Souza Neves
Thaís Reis Oliveira
Lilian Carla Carneiro
Nadya da Silva Castro Ragagnin

Keywords:

acute kidney injury, biomarkers, COVID-19, diagnosis, glomerular filtration, performance, prognosis, secondary manifestations, serum creatinine

Abstract

Acute kidney injury (AKI) is one of the main secondary manifestations developed in patients with COVID-19. Based on this aspect, the present study aimed to identify the main biomarkers used to predict acute kidney injury and prognosis in COVID-19 and gather information about the biomarkers studied. Articles published in the Virtual Health Library, between January 2020 and February 2022, in English, Portuguese and Spanish were evaluated, with the guiding question "What is the scientific evidence on new biomarkers for diagnosis and determination of the prognosis of induced acute kidney injury?" in COVID-19?". Initially, more than 75 thousand articles were identified, however, with the attribution of inclusion and exclusion criteria, 8 articles were selected and analyzed during the present study. The findings of the present review emphasize that early diagnosis has a strong influence on the prognosis of AKI and that new biomarkers are useful for detecting and predicting the prognosis of the injury early. The potential of these assays with new biomarkers proved to be significant and could allow their use in future research.

Downloads

Article PDF

How to Cite

Exploring Biomarkers for Early Prognosis of COVID-19-Induced Acute Kidney Injury: A Comprehensive Systematic Review. (2024). Global Journal of Medical Research, 24(F1), 49-59. https://doi.org/10.34257/GJMRFVOL24IS1PG49

Download Citation

References

(2021) WHO-Convened Global Study of Origins of SARS-CoV-2: China Part (Text Extract). 1(3), 125-132.

J Nicholas, E Tom, F Robert (2021) Doença do coronavírus 2019 (COVID-19).

Loami Martins (2020) Ocorrência de injúria renal aguda em pacientes internados por COVID-19 em um hospital público universitário em São Paulo, Brasil. 11.

T Levi, Souza Sp De, J Magalhães, De, Carvalho Ms De, Alb Cunha, Jgao Dantas (2013) Comparação dos critérios RIFLE, AKIN e KDIGO para predizer mortalidade em pacientes críticos. 25(4), 290-296.

José Lopes, Sofia Jorge (2013) The RIFLE and AKIN classifications for acute kidney injury: a critical and comprehensive review. 6(1), 8-14.

E Macedo (2011) Biomarcadores na injuria renal aguda. 1-114.

Luis Peres, Ademar Cunha Júnior, Alex Schäfer, Aline Silva, Arianne Gaspar, Deborah Scarpari, Julia Alves, Rodolfo Girelli Neto, Thaís Oliveira (2013) Biomarkers of acute kidney injury. 35(3), 229-236.

Kianoush Kashani, Wisit Cheungpasitporn, Claudio Ronco (2017) Biomarkers of acute kidney injury: the pathway from discovery to clinical adoption. 55(8), 1074-1089.

Y Koza (2016) Acute kidney injury: Current concepts and new insights. 8(1), 58-62.

Thelma Okay, C Cistatina (2002) Cistatina C: um novo marcador de função renal em crianças. 48(2), 112-113.

A Pereira (2006) Revisão sistemática da literatura sobre produtos usados tratamento de feridas. 129.

L Carneiro, J Paula, J Aguiar, P Ludvig (2017) CONCRETO AUTOCICATRIZANTE PELA INTRODUÇÃO DE BACTÉRIAS - UMA REVISÃO.

Mustafa Temiz, Ibrahim Hacibey, Ramazan Yazar, Mehmet Sevdi, Suat Kucuk, Gizem Alkurt, Levent Doganay, Gizem Dinler Doganay, Muhammet Dincer, Emrah Yuruk, Kerem Erkalp, Ahmet Muslumanoglu (2022) Altered kidney function induced by SARS-CoV-2 infection and acute kidney damage markers predict survival outcomes of COVID-19 patients: a prospective pilot study. 44(1), 233-240.

N Shakked, Oliveira Mhs De, I Cheruiyot, J Benoit, M Plebani, G Lippi (2022) Early prediction of COVID-19-associated acute kidney injury: Are serum NGAL and serum Cystatin C levels better than serum creatinine?. 102, 1-8.

Faeq Husain-Syed, Gianluca Villa, Jochen Wilhelm, Sara Samoni, Ulrich Matt, István Vadász, Khodr Tello, Birgit Jennert, Hartmut Dietrich, Janina Trauth, Shadi Kassoumeh, Borros Arneth, Harald Renz, Michael Sander, Susanne Herold, Werner Seeger, Stefan Schunk, Thimoteus Speer, Horst-Walter Birk, Claudio Ronco (2021) Renal markers for monitoring acute kidney injury transition to chronic kidney disease after COVID-19. 36(11), 2143-2147.

A Gradin, H Andersson, T Luther, S Anderberg, S Rubertsson, M Lipcsey, M Åberg, A Larsson, R Frithiof, M Hultström (2021) Urinary cytokines correlate with acute kidney injury in critically ill COVID-19 patients. 146, 155589.

Manuel Vogel, Julian Mustroph, Stephan Staudner, Simon Leininger, Ute Hubauer, Stefan Wallner, Christine Meindl, Frank Hanses, Markus Zimmermann, Lars Maier, Carsten Jungbauer, Julian Hupf (2021) Kidney injury molecule-1: potential biomarker of acute kidney injury and disease severity in patients with COVID-19. 34(4), 1007-1018.

Bianca Oliveira, Antonio Paranhos Filho, Eliane Guaraldo (2013) Identification of erosive processes with free geotechnologies.. 16, 1-17.

Yuexing Tu, Hui Wang, Renhua Sun, Yin Ni, Leilei Ma, Fei Xv, Xiuping Hu, Lingzhi Jiang, Aiping Wu, Xv Chen, Minhua Chen, Jingquan Liu, Fang Han (2014) Urinary netrin-1 and KIM-1 as early biomarkers for septic acute kidney injury. 36(10), 1559-1563.

Orfeas Liangos, Mary Perianayagam, Vishal Vaidya, Won Han, Ron Wald, Hocine Tighiouart, Robert Mackinnon, Lijun Li, Vaidyanathapuram Balakrishnan, Brian Pereira, Joseph Bonventre, Bertrand Jaber (2007) Urinary N-Acetyl-β-(D)-Glucosaminidase Activity and Kidney Injury Molecule-1 Level Are Associated with Adverse Outcomes in Acute Renal Failure. 18(3), 904-912.

Michael Haase, Prasad Devarajan, Anja Haase-Fielitz, Rinaldo Bellomo, Dinna Cruz, Gebhard Wagener, Catherine Krawczeski, Jay Koyner, Patrick Murray, Michael Zappitelli, Stuart Goldstein, Konstantinos Makris, Claudio Ronco, Johan Martensson, Claes-Roland Martling, Per Venge, Edward Siew, Lorraine Ware, T Ikizler, Peter Mertens (2011) The Outcome of Neutrophil Gelatinase-Associated Lipocalin-Positive Subclinical Acute Kidney Injury. 57(17), 1752-1761.

S Krishnasamy, A Sinha, A Bagga (2023) Management of Acute Kidney Injury in Critically Ill Children. 90, 481-491.

Stefan Schunk, Thimoteus Speer, Ioannis Petrakis, Danilo Fliser (2020) Dickkopf 3-a novel biomarker of the 'kidney injury continuum'. 36(5), 761-767.

Yusuke Fukao, Hajime Nagasawa, Yoshihito Nihei, Makoto Hiki, Toshio Naito, Masao Kihara, Tomohito Gohda, Seiji Ueda, Yusuke Suzuki (2021) COVID-19-induced acute renal tubular injury associated with elevation of serum inflammatory cytokine. 25(11), 1240-1246.

S Silva, Da (2020) O papel dos biomarcadores TIMP-2, IGFBP7 e L-FABP no diagnóstico da lesão renal aguda.

R Wang, M He, Y Kang (2021) A risk score based on procalcitonin for predicting acute kidney injury in COVID-19 patients. 35(6), 23805.

Silva Mr Castro Mc De, Da (2012) Procalcitonina no diagnóstico de doenças infecciosas. 10(6), 521-528.

R Indirli, A Bandera, L Valenti, F Ceriotti, A Modugno, M Tettamanti (2022) Prognostic value of copeptin and mid-regional proadrenomedullin in COVID-19-hospitalized patients. 52(5), 13753.